ÂÜÀòÂÒÂ×

Sarah Ball is an accomplished scientist with a robust background in medicine and pharmacology. Currently serving as a Principal Scientist at WaveBreak since October 2021, Sarah provides expertise in strategy and research and development pipeline programs. Previously, Sarah held various roles at Amgen, including Senior Scientist and Scientist, from January 2018 to September 2021. Additionally, Sarah worked as a Research Assistant at the University of Sydney during the same period and served as an Academic Tutor at Matrix Education from March 2019 to June 2021, as well as a High School Science Teacher. Sarah earned a Doctor of Philosophy (PhD) in Medicine from the University of Sydney in October 2021, following a Bachelor of Medical Science with Honors in Pharmacology/Neuroscience in November 2017.